These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31798896)

  • 1. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
    Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
    BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 5. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy.
    Yu D; Wang Z; Zhang X; Qu B; Cai Y; Ma S; Zhao Z; Simmons D
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3546-3554. PubMed ID: 34291804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and external validation of risk algorithms for cerebrovascular (re)hospitalisation in patients with type 2 diabetes: Two cohorts study.
    Yu D; Cai Y; Graffy J; Holman D; Zhao Z; Simmons D
    Diabetes Res Clin Pract; 2018 Oct; 144():74-81. PubMed ID: 30114459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes.
    Yu D; Shang J; Cai Y; Wang Z; Zhao B; Zhao Z; Simmons D
    Diabet Med; 2020 Oct; 37(10):1728-1736. PubMed ID: 31797436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 10. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
    BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy.
    Roumeliotis S; Roumeliotis A; Panagoutsos S; Giannakopoulou E; Papanas N; Manolopoulos VG; Passadakis P; Tavridou A
    J Diabetes Complications; 2017 Oct; 31(10):1527-1532. PubMed ID: 28734846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.
    Lutgers HL; Gerrits EG; Graaff R; Links TP; Sluiter WJ; Gans RO; Bilo HJ; Smit AJ
    Diabetologia; 2009 May; 52(5):789-97. PubMed ID: 19274450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2021 Jul; 20(1):133. PubMed ID: 34229668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
    Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
    Hippisley-Cox J; Coupland C; Robson J; Sheikh A; Brindle P
    BMJ; 2009 Mar; 338():b880. PubMed ID: 19297312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).
    Piniés JA; González-Carril F; Arteagoitia JM; Irigoien I; Altzibar JM; Rodriguez-Murua JL; Echevarriarteun L;
    Diabetologia; 2014 Nov; 57(11):2324-33. PubMed ID: 25212259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthostatic hypotension in diabetic patients-10-year follow-up study.
    Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
    J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum 25(OH)D
    Samefors M; Scragg R; Länne T; Nyström FH; Östgren CJ
    Diabet Med; 2017 Mar; 34(3):372-379. PubMed ID: 27862247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.